BIOMAT Database Logo BIOMAT Database Logo

[Leukotrienes and lipoxins]. 1989

J Stulík, and A Macela, and H Kovárová

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006893 Hydroxyeicosatetraenoic Acids Eicosatetraenoic acids substituted in any position by one or more hydroxy groups. They are important intermediates in a series of biosynthetic processes leading from arachidonic acid to a number of biologically active compounds such as prostaglandins, thromboxanes, and leukotrienes. HETE,Acids, Hydroxyeicosatetraenoic
D015289 Leukotrienes A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system. Leukotriene
D044045 Lipoxins Trihydroxy derivatives of eicosanoic acids. They are primarily derived from arachidonic acid, however eicosapentaenoic acid derivatives also exist. Many of them are naturally occurring mediators of immune regulation. Lipoxin

Related Publications

J Stulík, and A Macela, and H Kovárová
Leukotrienes, lipoxins, and hydroxyeicosatetraenoic acids.
January 1999, Methods in molecular biology (Clifton, N.J.),
J Stulík, and A Macela, and H Kovárová
Structural determination of leukotrienes and lipoxins.
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
J Stulík, and A Macela, and H Kovárová
[Lipoxins and leukotrienes, molecular signals of immunoreactions].
May 1989, Pharmazie in unserer Zeit,
J Stulík, and A Macela, and H Kovárová
Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.
September 1987, Science (New York, N.Y.),
J Stulík, and A Macela, and H Kovárová
Platelet-granulocyte interactions and the production of leukotrienes and lipoxins.
January 1990, Advances in prostaglandin, thromboxane, and leukotriene research,
J Stulík, and A Macela, and H Kovárová
Phospholipase A2 (PLA2) releases lipoxins and leukotrienes from endogenous sources.
January 1988, Annals of the New York Academy of Sciences,
J Stulík, and A Macela, and H Kovárová
Transcellular biosynthesis of leukotrienes and lipoxins via leukotriene A4 transfer.
October 1993, Trends in pharmacological sciences,
J Stulík, and A Macela, and H Kovárová
Formation and effects of leukotrienes and lipoxins in human bone marrow.
January 1993, Journal of lipid mediators,
J Stulík, and A Macela, and H Kovárová
The change in leukotrienes and lipoxins in activated mouse peritoneal macrophages.
April 2000, Biochimica et biophysica acta,
J Stulík, and A Macela, and H Kovárová
Reversed-phase ion-interaction chromatography of leukotrienes, lipoxins and related compounds.
May 1988, Journal of chromatography,
Copied contents to your clipboard!